Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1998 Feb;93(2):221–229. doi: 10.1046/j.1365-2567.1998.00403.x

Analysis of cytokine production and V beta T-cell receptor subsets in irradiated recipients receiving portal or peripheral venous reconstitution with allogeneic bone marrow cells, with or without additional anti-cytokine monoclonal antibodies.

R M Gorczynski 1, Z Chen 1, H Zeng 1, L Gorczynski 1, E Terzioglu 1
PMCID: PMC1364182  PMID: 9616372

Abstract

Irradiated (800 rads) AKR mice received intravenous (i.v.) reconstitution with a mixture of B10.BR T-depleted bone marrow cells and spleen cells. Only in groups of mice treated additionally with i.v. cyclophosphamide (Cy; 150 mg/kg), 24 hr before transplantation, was long-term (> 60% at 50 days) survival seen. In mice receiving only irradiation all animals died by 30 days post-transplantation. Histological changes consistent with graft-versus-host disease (GVHD) were seen in the liver of reconstituted mice at 30 days, along with an organ-specific increase in V beta 3 T-cell receptor-positive (TCR+) cells. No such increase in V beta 3 TCR+ cells was seen in the spleen from the same mice. These data are consistent with a tissue antigen-driven expansion of V beta 3 TCR+ cells associated with GVHD in the liver in this model. When we analysed cytokine production in vitro from CD3+ cells restimulated with 'host' (AKR) antigen-presenting cells (APC), we found a transition in cytokine production from preferential synthesis of type-1 cytokines [interleukin-2 (IL-2) and interferon-gamma (IFN-gamma)] at early times (day 15) post-reconstitution to increased production of type-2 cytokines [IL-4, transforming growth factor-beta (TGF-beta) and IL-10] at later times (day 30) post-reconstitution in Cy-treated recipients. Animals not receiving Cy did not show this 'switch' in cytokine production at later time points. We have observed a similar polarization in cytokine production, along with increased graft survival, in recipients of vascularized and non-vascularized allografts after portal venous (p.v.), but not i.v., pretransplant donor-specific immunization. We next studied AKR mice receiving 800 rads and subsequently reconstituted with B10.BR stem cells via the p.v. route. Again these mice showed prolonged survival (> 50% at 50 days), with polarization to IL-4, IL-10 and TGF-beta on restimulation of CD3+ cells in vitro at 30 days post-transplant and increased V beta 3 TCR+ cells in the liver. Infusion of anti-IL-12 monoclonal antibodies into irradiated mice receiving i.v. cell reconstitution produced a similar pattern of changes to those seen after p.v. reconstitution, while a combination of anti-IL-10 and anti-TGF-beta monoclonal antibodies reversed the changes seen after p.v. reconstitution. These data are consistent with an important role for differential cytokine production in the regulation of GVHD following allogeneic bone marrow transplantation.

Full text

PDF
221

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armitage J. O. Bone marrow transplantation. N Engl J Med. 1994 Mar 24;330(12):827–838. doi: 10.1056/NEJM199403243301206. [DOI] [PubMed] [Google Scholar]
  2. Brochu S., Baron C., Hétu F., Roy D. C., Perreault C. Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras. J Immunol. 1995 Dec 1;155(11):5104–5114. [PubMed] [Google Scholar]
  3. Bunjes D., Theobald M., Nierle T., Arnold R., Heimpel H. Presence of host-specific interleukin 2-secreting T helper cell precursors correlates closely with active primary and secondary chronic graft-versus-host disease. Bone Marrow Transplant. 1995 May;15(5):727–732. [PubMed] [Google Scholar]
  4. Cavazzana-Calvo M., Stephan J. L., Sarnacki S., Chevret S., Fromont C., de Coene C., Le Deist F., Guy-Grand D., Fischer A. Attenuation of graft-versus-host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination. Blood. 1994 Jan 1;83(1):288–298. [PubMed] [Google Scholar]
  5. Duval M., Yotnda P., Bensussan A., Oudhiri N., Guidal C., Rohrlich P., Boumsell L., Grandchamp B., Vilmer E. Potential antileukemic effect of gamma delta T cells in acute lymphoblastic leukemia. Leukemia. 1995 May;9(5):863–868. [PubMed] [Google Scholar]
  6. Ferrara J. L. Cytokine dysregulation as a mechanism of graft versus host disease. Curr Opin Immunol. 1993 Oct;5(5):794–799. doi: 10.1016/0952-7915(93)90139-j. [DOI] [PubMed] [Google Scholar]
  7. Gorczynski R. M., Adams R. B., Levy G. A., Chung S. W. Correlation of peripheral blood lymphocyte and intragraft cytokine mRNA expression with rejection in orthotopic liver transplantation. Surgery. 1996 Sep;120(3):496–502. doi: 10.1016/s0039-6060(96)80069-9. [DOI] [PubMed] [Google Scholar]
  8. Gorczynski R. M. Adoptive transfer of unresponsiveness to allogeneic skin grafts with hepatic gamma delta + T cells. Immunology. 1994 Jan;81(1):27–35. [PMC free article] [PubMed] [Google Scholar]
  9. Gorczynski R. M., Chan Z., Chung S., Cohen Z., Levy G., Sullivan B., Fu X. M. Prolongation of rat small bowel or renal allograft survival by pretransplant transfusion and/or by varying the route of allograft venous drainage. Transplantation. 1994 Oct 15;58(7):816–820. [PubMed] [Google Scholar]
  10. Gorczynski R. M., Chen Z., Hoang Y., Rossi-Bergman B. A subset of gamma delta T-cell receptor-positive cells produce T-helper type-2 cytokines and regulate mouse skin graft rejection following portal venous pretransplant preimmunization. Immunology. 1996 Mar;87(3):381–389. doi: 10.1046/j.1365-2567.1996.481554.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gorczynski R. M., Cohen Z., Fu X. M., Hua Z., Sun Y., Chen Z. Interleukin-13, in combination with anti-interleukin-12, increases graft prolongation after portal venous immunization with cultured allogeneic bone marrow-derived dendritic cells. Transplantation. 1996 Dec 15;62(11):1592–1600. doi: 10.1097/00007890-199612150-00012. [DOI] [PubMed] [Google Scholar]
  12. Gorczynski R. M., Cohen Z., Leung Y., Chen Z. Gamma delta TCR+ hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allograft survival in vivo. J Immunol. 1996 Jul 15;157(2):574–581. [PubMed] [Google Scholar]
  13. Gorczynski R. M., Holmes W. Specific manipulation in vivo of immunity to skin grafts bearing multiple minor histocompatibility differences. Immunol Lett. 1991 Feb;27(2):163–171. doi: 10.1016/0165-2478(91)90145-z. [DOI] [PubMed] [Google Scholar]
  14. Gorczynski R. M. Regulation of IFN-gamma and IL-10 synthesis in vivo, as well as continuous antigen exposure, is associated with tolerance to murine skin allografts. Cell Immunol. 1995 Feb;160(2):224–231. doi: 10.1016/0008-8749(95)80032-e. [DOI] [PubMed] [Google Scholar]
  15. Gorczynski R. M., Wojcik D. A role for nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion. J Immunol. 1994 Feb 15;152(4):2011–2019. [PubMed] [Google Scholar]
  16. Goulmy E., Schipper R., Pool J., Blokland E., Falkenburg J. H., Vossen J., Gratwohl A., Vogelsang G. B., van Houwelingen H. C., van Rood J. J. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med. 1996 Feb 1;334(5):281–285. doi: 10.1056/NEJM199602013340501. [DOI] [PubMed] [Google Scholar]
  17. Howell C. D., Li J., Roper E., Kotzin B. L. Biased liver T cell receptor V beta repertoire in a murine graft-versus-host disease model. J Immunol. 1995 Sep 1;155(5):2350–2358. [PubMed] [Google Scholar]
  18. Kappler J. W., Roehm N., Marrack P. T cell tolerance by clonal elimination in the thymus. Cell. 1987 Apr 24;49(2):273–280. doi: 10.1016/0092-8674(87)90568-x. [DOI] [PubMed] [Google Scholar]
  19. Kelso A. Th1 and Th2 subsets: paradigms lost? Immunol Today. 1995 Aug;16(8):374–379. doi: 10.1016/0167-5699(95)80004-2. [DOI] [PubMed] [Google Scholar]
  20. Krenger W., Snyder K. M., Byon J. C., Falzarano G., Ferrara J. L. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol. 1995 Jul 15;155(2):585–593. [PubMed] [Google Scholar]
  21. Mosmann T. R., Coffman R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145–173. doi: 10.1146/annurev.iy.07.040189.001045. [DOI] [PubMed] [Google Scholar]
  22. Schwarer A. P., Jiang Y. Z., Deacock S., Brookes P. A., Barrett A. J., Goldman J. M., Batchelor J. R., Lechler R. I. Comparison of helper and cytotoxic antirecipient T cell frequencies in unrelated bone marrow transplantation. Transplantation. 1994 Dec 15;58(11):1198–1203. [PubMed] [Google Scholar]
  23. Sprent J., Hurd M., Schaefer M., Heath W. Split tolerance in spleen chimeras. J Immunol. 1995 Feb 1;154(3):1198–1206. [PubMed] [Google Scholar]
  24. Sykes M., Abraham V. S., Harty M. W., Pearson D. A. IL-2 reduces graft-versus-host disease and preserves a graft-versus-leukemia effect by selectively inhibiting CD4+ T cell activity. J Immunol. 1993 Jan 1;150(1):197–205. [PubMed] [Google Scholar]
  25. Sykes M., Harty M. W., Szot G. L., Pearson D. A. Interleukin-2 inhibits graft-versus-host disease-promoting activity of CD4+ cells while preserving CD4- and CD8-mediated graft-versus-leukemia effects. Blood. 1994 May 1;83(9):2560–2569. [PubMed] [Google Scholar]
  26. Sykes M., Szot G. L., Nguyen P. L., Pearson D. A. Interleukin-12 inhibits murine graft-versus-host disease. Blood. 1995 Sep 15;86(6):2429–2438. [PubMed] [Google Scholar]
  27. Takaku F. Clinical application of cytokines for cancer treatment. Oncology. 1994 Mar-Apr;51(2):123–128. doi: 10.1159/000227326. [DOI] [PubMed] [Google Scholar]
  28. Theobald M. Predicting graft-versus-host disease. Curr Opin Immunol. 1995 Oct;7(5):649–655. doi: 10.1016/0952-7915(95)80072-7. [DOI] [PubMed] [Google Scholar]
  29. Via C. S., Rus V., Gately M. K., Finkelman F. D. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. J Immunol. 1994 Nov 1;153(9):4040–4047. [PubMed] [Google Scholar]
  30. van der Harst D., Goulmy E., Falkenburg J. H., Kooij-Winkelaar Y. M., van Luxemburg-Heijs S. A., Goselink H. M., Brand A. Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood. 1994 Feb 15;83(4):1060–1066. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES